Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA-Binding Proteins | 9 | 2010 | 215 | 1.490 |
Why?
|
| Phosphoproteins | 7 | 2010 | 202 | 1.360 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 7 | 2010 | 174 | 0.870 |
Why?
|
| DNA, Neoplasm | 6 | 2001 | 95 | 0.780 |
Why?
|
| Antineoplastic Agents | 8 | 2009 | 1070 | 0.750 |
Why?
|
| RNA, Messenger | 7 | 2009 | 1663 | 0.750 |
Why?
|
| DNA Topoisomerases, Type II | 6 | 2006 | 13 | 0.730 |
Why?
|
| Oligodeoxyribonucleotides | 3 | 2010 | 35 | 0.710 |
Why?
|
| Genes, bcl-2 | 3 | 2008 | 10 | 0.690 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2009 | 116 | 0.650 |
Why?
|
| Nuclear Matrix | 4 | 2006 | 5 | 0.590 |
Why?
|
| Teniposide | 4 | 2002 | 5 | 0.530 |
Why?
|
| RNA Stability | 5 | 2010 | 55 | 0.490 |
Why?
|
| Aptamers, Nucleotide | 3 | 2010 | 15 | 0.460 |
Why?
|
| Apoptosis | 6 | 2008 | 1640 | 0.420 |
Why?
|
| DNA | 2 | 2006 | 597 | 0.380 |
Why?
|
| DNA Replication | 4 | 2001 | 167 | 0.370 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2009 | 29 | 0.360 |
Why?
|
| DNA Damage | 2 | 2002 | 190 | 0.340 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2010 | 167 | 0.340 |
Why?
|
| Cell Membrane | 1 | 2010 | 523 | 0.340 |
Why?
|
| Leukemia | 5 | 2010 | 117 | 0.310 |
Why?
|
| Cell Line, Tumor | 6 | 2011 | 1849 | 0.300 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2007 | 44 | 0.290 |
Why?
|
| Thiobarbiturates | 1 | 2006 | 4 | 0.280 |
Why?
|
| Deoxyribonucleases | 1 | 2006 | 8 | 0.280 |
Why?
|
| Tumor Cells, Cultured | 7 | 2002 | 852 | 0.260 |
Why?
|
| Membrane Proteins | 1 | 2009 | 617 | 0.260 |
Why?
|
| Enzyme Inhibitors | 2 | 2006 | 659 | 0.260 |
Why?
|
| Tretinoin | 1 | 2004 | 92 | 0.250 |
Why?
|
| Protein Binding | 6 | 2010 | 1027 | 0.220 |
Why?
|
| Vidarabine | 1 | 2001 | 12 | 0.200 |
Why?
|
| Cytarabine | 1 | 2001 | 44 | 0.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2009 | 756 | 0.200 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 492 | 0.200 |
Why?
|
| HL-60 Cells | 5 | 2009 | 50 | 0.190 |
Why?
|
| Antigens, Surface | 2 | 2010 | 71 | 0.180 |
Why?
|
| RNA, Neoplasm | 3 | 2010 | 76 | 0.180 |
Why?
|
| Humans | 23 | 2011 | 68525 | 0.160 |
Why?
|
| Isoenzymes | 2 | 1996 | 308 | 0.160 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 1533 | 0.160 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 1997 | 12 | 0.150 |
Why?
|
| Leukemia, T-Cell | 1 | 1997 | 21 | 0.150 |
Why?
|
| Etoposide | 1 | 1996 | 64 | 0.150 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 1996 | 88 | 0.140 |
Why?
|
| Topoisomerase II Inhibitors | 3 | 2006 | 5 | 0.140 |
Why?
|
| Models, Biological | 2 | 2010 | 981 | 0.140 |
Why?
|
| IMP Dehydrogenase | 1 | 1995 | 2 | 0.130 |
Why?
|
| Guanosine Triphosphate | 1 | 1995 | 65 | 0.130 |
Why?
|
| Nuclear Proteins | 1 | 1996 | 271 | 0.130 |
Why?
|
| Polyribosomes | 2 | 2010 | 24 | 0.120 |
Why?
|
| Animals | 7 | 2011 | 20877 | 0.120 |
Why?
|
| ELAV-Like Protein 1 | 2 | 2010 | 18 | 0.120 |
Why?
|
| ELAV Proteins | 2 | 2010 | 17 | 0.120 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2011 | 332 | 0.110 |
Why?
|
| Mice, SCID | 2 | 2011 | 238 | 0.110 |
Why?
|
| RNA, Small Interfering | 3 | 2011 | 434 | 0.110 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2011 | 37 | 0.100 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2011 | 63 | 0.100 |
Why?
|
| Cell Nucleus | 2 | 2007 | 305 | 0.100 |
Why?
|
| Protein Phosphatase 2 | 1 | 2011 | 67 | 0.100 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2011 | 63 | 0.100 |
Why?
|
| Protein Sorting Signals | 1 | 2010 | 11 | 0.100 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2010 | 34 | 0.090 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein D | 1 | 2010 | 6 | 0.090 |
Why?
|
| Cricetulus | 1 | 2010 | 98 | 0.090 |
Why?
|
| 3' Untranslated Regions | 1 | 2010 | 56 | 0.090 |
Why?
|
| CHO Cells | 1 | 2010 | 161 | 0.090 |
Why?
|
| Cricetinae | 1 | 2010 | 262 | 0.090 |
Why?
|
| Genes, myc | 2 | 2002 | 26 | 0.090 |
Why?
|
| Biological Transport | 1 | 2010 | 210 | 0.090 |
Why?
|
| Mice | 4 | 2011 | 8472 | 0.090 |
Why?
|
| Lysophospholipids | 1 | 2011 | 209 | 0.090 |
Why?
|
| K562 Cells | 1 | 2009 | 44 | 0.090 |
Why?
|
| Kinetics | 2 | 2004 | 1047 | 0.090 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2011 | 200 | 0.090 |
Why?
|
| Neoplasm Transplantation | 1 | 2009 | 160 | 0.090 |
Why?
|
| Mice, Inbred NOD | 1 | 2009 | 138 | 0.090 |
Why?
|
| Sphingosine | 1 | 2011 | 315 | 0.090 |
Why?
|
| Recombinant Proteins | 2 | 2009 | 742 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 2009 | 248 | 0.080 |
Why?
|
| Okadaic Acid | 2 | 2003 | 22 | 0.080 |
Why?
|
| Cytoplasm | 1 | 2007 | 155 | 0.070 |
Why?
|
| Paclitaxel | 2 | 2003 | 140 | 0.070 |
Why?
|
| Jurkat Cells | 1 | 2006 | 59 | 0.070 |
Why?
|
| Cytochromes c | 1 | 2006 | 75 | 0.070 |
Why?
|
| In Vitro Techniques | 1 | 2007 | 765 | 0.070 |
Why?
|
| Catalysis | 1 | 2006 | 123 | 0.070 |
Why?
|
| Cytosol | 1 | 2006 | 123 | 0.070 |
Why?
|
| Molecular Weight | 1 | 2006 | 358 | 0.070 |
Why?
|
| Cell Division | 2 | 2004 | 541 | 0.070 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 1996 | 77 | 0.070 |
Why?
|
| Neoplasms | 1 | 1996 | 1660 | 0.060 |
Why?
|
| B-Lymphocytes | 1 | 2007 | 329 | 0.060 |
Why?
|
| Gene Expression | 1 | 2007 | 770 | 0.060 |
Why?
|
| DNA Primers | 1 | 2004 | 302 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2009 | 624 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2006 | 791 | 0.060 |
Why?
|
| Adenosine Triphosphate | 2 | 1995 | 314 | 0.060 |
Why?
|
| Cell Survival | 2 | 1996 | 901 | 0.060 |
Why?
|
| Base Sequence | 1 | 2004 | 1015 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2004 | 236 | 0.050 |
Why?
|
| Necrosis | 1 | 2002 | 239 | 0.050 |
Why?
|
| Cisplatin | 1 | 2002 | 192 | 0.050 |
Why?
|
| Mitochondria | 1 | 2006 | 643 | 0.050 |
Why?
|
| Tritium | 1 | 2000 | 101 | 0.050 |
Why?
|
| Nucleic Acid Conformation | 1 | 2000 | 92 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2004 | 1034 | 0.050 |
Why?
|
| Binding Sites | 1 | 2000 | 631 | 0.040 |
Why?
|
| Enzyme Stability | 1 | 1997 | 30 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 1997 | 122 | 0.040 |
Why?
|
| Female | 3 | 2009 | 38015 | 0.040 |
Why?
|
| Molecular Biology | 1 | 1996 | 31 | 0.040 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1996 | 70 | 0.040 |
Why?
|
| Phosphonoacetic Acid | 1 | 1996 | 5 | 0.040 |
Why?
|
| Bromodeoxyuridine | 1 | 1996 | 37 | 0.040 |
Why?
|
| Male | 2 | 2009 | 37281 | 0.030 |
Why?
|
| Aspartic Acid | 1 | 1996 | 65 | 0.030 |
Why?
|
| RNA Nucleotidyltransferases | 1 | 1995 | 2 | 0.030 |
Why?
|
| Ribonucleosides | 1 | 1995 | 5 | 0.030 |
Why?
|
| DNA Primase | 1 | 1995 | 6 | 0.030 |
Why?
|
| Nucleosomes | 1 | 1995 | 25 | 0.030 |
Why?
|
| Mycophenolic Acid | 1 | 1995 | 62 | 0.030 |
Why?
|
| Radiation, Ionizing | 1 | 1995 | 37 | 0.030 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 1995 | 57 | 0.030 |
Why?
|
| Sodium Chloride | 1 | 1995 | 136 | 0.030 |
Why?
|
| Chromatin | 1 | 1995 | 76 | 0.030 |
Why?
|
| Blotting, Western | 1 | 1996 | 954 | 0.030 |
Why?
|
| Time Factors | 2 | 2000 | 4655 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 1996 | 267 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 1996 | 475 | 0.030 |
Why?
|
| Cell Line | 1 | 1996 | 1752 | 0.030 |
Why?
|
| Imatinib Mesylate | 1 | 2011 | 26 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2011 | 85 | 0.020 |
Why?
|
| Benzamides | 1 | 2011 | 156 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2010 | 237 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2011 | 178 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2009 | 36 | 0.020 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2009 | 3 | 0.020 |
Why?
|
| Piperazines | 1 | 2011 | 206 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 322 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 132 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 196 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 1199 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 467 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2003 | 124 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2011 | 2688 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2003 | 306 | 0.010 |
Why?
|
| Tumor Stem Cell Assay | 1 | 1996 | 30 | 0.010 |
Why?
|
| Nucleotides | 1 | 1996 | 29 | 0.010 |
Why?
|